Photo courtesy of the Northwestern Medicine Chicago Proton Center
Improving therapy and cancer outcomes through research.
Mission: To improve the survival outcomes of cancer patients and the quality of life for affected individuals
The Proton Collaborative Group (PCG) was founded in 2009 by a group of radiation oncologists whose primary mission was to improve the survival outcomes of cancer patients and the quality of life for affected individuals. These oncologists strongly believed that collaborating to develop new research protocols and sharing those results across multiple treatment centers would best serve their mission.
To date, PCG research data has been used in close to 50 scientific manuscripts, posters and conference presentations. PCG has been represented at 20 industry conferences and appeared in seven distinct peer-reviewed journals over the past three years. Having partnered with nine treatment centers to collect data, there are more than 5,800 patients in the PCG registry. Learn more about PCG
The inclined beam technology can treat 70 percent of tumors using the industry standard gantry, but in a space half the size. Photo taken at the ProCure Proton Therapy Center in Oklahoma City.
PCG is thrilled to announce that Charles Simone, MD, from the Maryland Proton Treatment Center, has been appointed as the Chairman of the PCG Executive Council. Dr. Simone currently serves as the chai...